Case Study
Tribal Opioid Settlements
BrownGreer assists Directors overseeing the settlement funds in the American Indian Tribal Nations settlements.
Key Statistics
$1 billion
Fund
100+
Tribal Nations
BrownGreer assists Directors overseeing the settlement funds in the American Indian Tribal Nations settlements.
These settlements involve Purdue Pharma and Mallinckrodt in federal bankruptcy courts. They also involve multidistrict litigation in federal district court, involving the three largest pharmacies: Walmart, CVS, and Walgreens (“Pharmacies”), several manufacturers, Janssen Pharmaceuticals (and its parent company Johnson & Johnson), Teva and Allergan (“Manufacturers”); three pharmaceutical distributors (McKesson, Cardinal Health, and AmerisourceBergen (referred to as the “Distributors”).
In this role, we issue notices and maintain the public website, collect participation forms, perform calculations and issue payments, collect opioid use reports and coordinate Naloxone distributions.
Complete Solutions for Complex Claims
Find out how BrownGreer can help.
Related
CASE STUDIES
-
JUUL Youth Marketing and Personal Injury Settlements
BrownGreer serves as the administrator in a series of settlements to resolve claims by cities and towns, school districts, tribal nations, and individual plaintiffs against e-cigarette maker JUUL and parent company Altria alleging that the nicotine-containing product was marketed to teenagers.
Read more -
National Opioid Settlements
BrownGreer serves as the Directing Administrator for the National Opioid Settlement, a group of finalized settlements totaling over $45 billion between state/local subdivision governments and various entities in the opioid pharmaceutical supply chain including: (1) the “Big Three” drug distributors – AmerisourceBergen, Cardinal Health, and McKesson; (2) drug manufacturers – Johnson & Johnson, Teva, and Allergan; and (3) pharmacy retailers – CVS, Walgreens, Walmart, and Kroger.
Read more